An Early Catch: Multisystem Inflammatory Syndrome in Adults (MIS-A) in a Young Adult Male With COVID-19 Exposure.

academic rheumatology covid 19 internal medicine and rheumatology intravenous immune globulin multisystem inflammatory syndrome multisystem inflammatory syndrome in adult multisystem inflammatory syndrome in children pulmonary critical care sars-cov-2 vv ecmo

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2022
Historique:
accepted: 02 07 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

While severe acute respiratory syndrome (SARS) is the most common presentation of coronavirus disease 2019 (COVID-19) infection, several short- and long-term complications from COVID-19 infection are also being recognized. One such complication with life-threatening consequences is known as multisystem inflammatory syndrome in adults (MIS-A). While the phenomenon of multisystem inflammatory syndrome in children (MIS-C) is more recognized, the pathophysiology of both presentations remains a mystery currently. Several theories have been put forward however no consensus has been established yet. We present the case of a 20-year-old male who was admitted to the intensive care unit for a multisystem illness characterized by severe biventricular failure, profound shock, and acute liver and kidney injuries. The severity of illness necessitated the treatment with mechanical ventilation, extracorporeal membrane oxygenation (ECMO), vasopressors, and continuous veno-venous hemofiltration (CVVH). The patient was treated with one dose of intravenous immune globulin (IVIG). In association with the foregoing treatment, the patient made dramatic recovery and came off pulmonary, hemodynamic, and renal support within a week and made remarkably quick and full recovery. This case highlights a rare presentation of a COVID-19 complication that requires prompt recognition, supportive care, and empiric treatment that led to a favorable outcome in this case.

Identifiants

pubmed: 35815299
doi: 10.7759/cureus.26519
pmc: PMC9259070
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e26519

Informations de copyright

Copyright © 2022, Khokhar et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
JAMA Netw Open. 2021 Sep 01;4(9):e2126456
pubmed: 34550381
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Chest. 2021 Feb;159(2):471-472
pubmed: 33285106
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Clin Infect Dis. 2021 Nov 28;:
pubmed: 34849680

Auteurs

Farzam Khokhar (F)

Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.

Zainab Bhura (Z)

Internal Medicine, University Health Network, Toronto, CAN.

Muhammad Muneeb (M)

Internal Medicine, Ziauddin University, Karachi, PAK.

Garima Singh (G)

Internal Medicine, Saint Vincent Hospital, Worcester, USA.

Jianghong Yu (J)

Rheumatology, State University of New York Upstate Medical University, Syracuse, USA.

Classifications MeSH